{"id":61900,"date":"2025-09-22T13:04:04","date_gmt":"2025-09-22T11:04:04","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/"},"modified":"2025-09-22T13:04:04","modified_gmt":"2025-09-22T11:04:04","slug":"confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/","title":{"rendered":"Confluence Genetics Partners With Ag Partners Cooperative to Increase Commercial Acres of ProVIA\u2122 Soybeans Following Successful Broiler Performance Trials"},"content":{"rendered":"<div>\n<p>\n<b>Following initial trial with a large poultry integrator completed September 2024, second trial validates benefits and companies offer identity preserved grower programs for 2026 crop.<\/b><\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20250922272861\/en\/2585586\/5\/provia-availability-for-2026-season.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250922272861\/en\/2585586\/22\/provia-availability-for-2026-season.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250922272861\/en\/2585586\/5\/provia-availability-for-2026-season.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250922272861\/en\/2585586\/21\/provia-availability-for-2026-season.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250922272861\/en\/2585583\/5\/Confluence-Genetics-Horizontal%403x.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250922272861\/en\/2585583\/22\/Confluence-Genetics-Horizontal%403x.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20250922272861\/en\/2585583\/5\/Confluence-Genetics-Horizontal%403x.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250922272861\/en\/2585583\/21\/Confluence-Genetics-Horizontal%403x.jpg\"><\/a><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Consistent Results<\/b>: Confluence Genetics&#8217; second broiler trial with a major poultry integrator confirmed that soybean meal derived from ProVIA\u2122 soybeans improves broiler performance, delivering 2.2% higher final body weight and 2.6% better feed conversion compared to conventional soybean meal.<\/li>\n<li>\n<b>Proven Technology<\/b>: ProVIA\u2122 Ultra-High Protein, Low Oligosaccharide (UHP-LO) soybeans contain 14% higher protein and 90% fewer anti-nutritional compounds than conventional soybeans, providing higher metabolizable energy and allowing for more efficient diet formulations.<\/li>\n<li>\n<b>Commercial Expansion<\/b>: Confluence Genetics has partnered with Ag Partners Cooperative to make ProVIA\u2122 soybean varieties commercially available to growers for the 2026 growing season.<\/li>\n<\/ul>\n<p>ST. LOUIS&#8211;(BUSINESS WIRE)&#8211;Confluence Genetics, LLC. has received positive results from a second collaborative feeding trial with a major poultry integrator, validating the consistent performance benefits of soybean meal derived from the Company&#8217;s Ultra-High Protein, Low Oligosaccharide (UHP-LO) ProVIA\u2122 soybeans. The 42-day broiler trial replicated results from an initial study with the same integrator, demonstrating that UHP-LO soybean meal can reliably improve broiler performance while reducing production costs.<\/p>\n<p>\nResults from the large-scale trial involving 3,840 broilers showed that birds fed UHP-LO soybean meal achieved significantly higher final body weights and improved feed conversion ratios compared to those fed conventional soybean meal. Specifically, broiler chickens fed UHP-LO soybean meal achieved a 2.2 percent increase in final body weight and a 2.6 percent improvement in mortality-adjusted feed conversion ratio. These findings reinforce the first trial results, which also showed significant improvements in final body weight and feed conversion ratio, confirming the consistent value proposition of UHP-LO soybean meal.<\/p>\n<p>\n\u201cThe repeated results seen in these two trials reinforce the value and commercial viability of our ProVIA\u2122 soybean technology in poultry feed,\u201d said Aaron Robinson, COO at Confluence Genetics. \u201cThe enhanced nutritional profile of ultra-high protein low oligosaccharide soybean meal made from ProVIA\u2122 soybeans delivers meaningful improvements in feed conversion and animal performance giving poultry producers confidence to adopt this new technology.\u201d<\/p>\n<p>\nThe superior performance of UHP-LO soybean meal stems from Confluence Genetics&#8217; proprietary soybean genetics, which deliver 14 percent higher crude protein content and over 90 percent reduction in anti-nutritional oligosaccharides compared to conventional soybeans. These quality improvements translate to higher metabolizable energy levels, allowing nutritionists to formulate more efficient diets with reduced inclusion of supplemental fats and other costly ingredients.<\/p>\n<p>\nBuilding on these proven trial results, Confluence Genetics is working with Ag Partners Cooperative to offer an identity preserved (IP) soy program for the 2026 growing season. Ag Partners Cooperative\u2019s IP program will provide growers access to Confluence Genetics ProVIA\u2122 soybean varieties to ensure a reliable source of premium soybeans for poultry end-markets. This IP program will provide growers in Missouri, Kansas, and Iowa with the opportunity to generate higher returns on soybean acres for the 2026 growing season. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fconfluence.ag%2Fproducts%2Fpartner-programs%2F&amp;esheet=54327073&amp;newsitemid=20250922272861&amp;lan=en-US&amp;anchor=https%3A%2F%2Fconfluence.ag%2Fproducts%2Fpartner-programs%2F&amp;index=1&amp;md5=9d80eb39bbe0d917465a33bab1a1e8c3\" rel=\"nofollow\" shape=\"rect\">https:\/\/confluence.ag\/products\/partner-programs\/<\/a><\/p>\n<p>\n&#8220;We&#8217;re excited to partner with Confluence Genetics to bring ProVIA\u2122 UHP-LO soybeans to our grower network through our 2026 identity preserved program,&#8221; said Andy Determan, Director of IP at Ag Partners Coop. &#8220;The consistent trial results we&#8217;re seeing with major poultry integrators demonstrate real value for both our soybean growers and their end customers. This partnership allows us to offer our producers a premium soybean variety with proven performance benefits while helping build a reliable supply chain for the growing demand in specialty animal nutrition. We believe ProVIA\u2122 represents the future of high-value soybean production.&#8221;<\/p>\n<p>\nWith consistent performance data from five commercial poultry trials across broilers and turkeys, Confluence Genetics is confident that ProVIA\u2122 soybeans generate significant value for the poultry industry.<\/p>\n<p>\n<b>About Confluence Genetics<\/b><\/p>\n<p>\nConfluence Genetics is a seed innovation company where the forces of nature and technology converge\u2014unlocking the genetic diversity of soy quality traits through proprietary genetics, its AI-driven CropOS\u00ae platform, and its Crop Accelerator. Confluence Genetics collaborates with strategic partners throughout the agribusiness value chain to meet the demand for better feed, food, and fuel. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fconfluence.ag%2F&amp;esheet=54327073&amp;newsitemid=20250922272861&amp;lan=en-US&amp;anchor=confluence.ag&amp;index=2&amp;md5=9a21a180ae92f7a31ca1967ecd5d899a\" rel=\"nofollow\" shape=\"rect\">confluence.ag<\/a>.<\/p>\n<p>\n<b>About Ag Partners Cooperative<\/b><\/p>\n<p>\nAg Partners Cooperative, Inc. is a full-service, patron-owned cooperative, serving more than twenty communities in northeast Kansas, southeast Nebraska, and northwest Missouri. Ag Partners Cooperative has worked alongside generations of patrons in the communities that they serve. Looking ahead at the ever-changing world and ag industry, Ag Partners Cooperative looks forward to working and growing together to help feed the world. For more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fagpartnerscoop.com%2F&amp;esheet=54327073&amp;newsitemid=20250922272861&amp;lan=en-US&amp;anchor=agpartnerscoop.com&amp;index=3&amp;md5=383fe8fb0973a44ff14dc43982ef3caa\" rel=\"nofollow\" shape=\"rect\">agpartnerscoop.com<\/a><\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media Contacts:<\/b> <b>Confluence Genetics: <\/b>email: <a target=\"_blank\" href=\"&#109;a&#x69;l&#x74;o&#x3a;m&#x65;d&#x69;a&#x40;&#99;&#x6f;&#110;&#x66;&#108;&#x75;&#101;&#x6e;&#99;&#x65;&#46;&#x61;&#103;\" rel=\"nofollow\" shape=\"rect\">m&#101;&#100;&#105;&#x61;&#x40;&#x63;on&#102;&#108;&#x75;&#x65;&#x6e;&#x63;e&#46;&#97;&#103;<\/a>; phone: 314-594-7624<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Following initial trial with a large poultry integrator completed September 2024, second trial validates benefits and companies offer identity preserved grower programs for 2026 crop. Consistent Results: Confluence Genetics&#8217; second broiler trial with a major poultry integrator confirmed that soybean meal derived from ProVIA\u2122 soybeans improves broiler performance, delivering 2.2% higher final body weight and &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61900","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Confluence Genetics Partners With Ag Partners Cooperative to Increase Commercial Acres of ProVIA\u2122 Soybeans Following Successful Broiler Performance Trials - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Confluence Genetics Partners With Ag Partners Cooperative to Increase Commercial Acres of ProVIA\u2122 Soybeans Following Successful Broiler Performance Trials - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Following initial trial with a large poultry integrator completed September 2024, second trial validates benefits and companies offer identity preserved grower programs for 2026 crop. Consistent Results: Confluence Genetics&#8217; second broiler trial with a major poultry integrator confirmed that soybean meal derived from ProVIA\u2122 soybeans improves broiler performance, delivering 2.2% higher final body weight and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-22T11:04:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250922272861\/en\/2585586\/22\/provia-availability-for-2026-season.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Confluence Genetics Partners With Ag Partners Cooperative to Increase Commercial Acres of ProVIA\u2122 Soybeans Following Successful Broiler Performance Trials\",\"datePublished\":\"2025-09-22T11:04:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\\\/\"},\"wordCount\":764,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250922272861\\\/en\\\/2585586\\\/22\\\/provia-availability-for-2026-season.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\\\/\",\"name\":\"Confluence Genetics Partners With Ag Partners Cooperative to Increase Commercial Acres of ProVIA\u2122 Soybeans Following Successful Broiler Performance Trials - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250922272861\\\/en\\\/2585586\\\/22\\\/provia-availability-for-2026-season.jpg\",\"datePublished\":\"2025-09-22T11:04:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250922272861\\\/en\\\/2585586\\\/22\\\/provia-availability-for-2026-season.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250922272861\\\/en\\\/2585586\\\/22\\\/provia-availability-for-2026-season.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Confluence Genetics Partners With Ag Partners Cooperative to Increase Commercial Acres of ProVIA\u2122 Soybeans Following Successful Broiler Performance Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Confluence Genetics Partners With Ag Partners Cooperative to Increase Commercial Acres of ProVIA\u2122 Soybeans Following Successful Broiler Performance Trials - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/","og_locale":"en_US","og_type":"article","og_title":"Confluence Genetics Partners With Ag Partners Cooperative to Increase Commercial Acres of ProVIA\u2122 Soybeans Following Successful Broiler Performance Trials - Pharma Trend","og_description":"Following initial trial with a large poultry integrator completed September 2024, second trial validates benefits and companies offer identity preserved grower programs for 2026 crop. Consistent Results: Confluence Genetics&#8217; second broiler trial with a major poultry integrator confirmed that soybean meal derived from ProVIA\u2122 soybeans improves broiler performance, delivering 2.2% higher final body weight and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/","og_site_name":"Pharma Trend","article_published_time":"2025-09-22T11:04:04+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250922272861\/en\/2585586\/22\/provia-availability-for-2026-season.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Confluence Genetics Partners With Ag Partners Cooperative to Increase Commercial Acres of ProVIA\u2122 Soybeans Following Successful Broiler Performance Trials","datePublished":"2025-09-22T11:04:04+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/"},"wordCount":764,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250922272861\/en\/2585586\/22\/provia-availability-for-2026-season.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/","url":"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/","name":"Confluence Genetics Partners With Ag Partners Cooperative to Increase Commercial Acres of ProVIA\u2122 Soybeans Following Successful Broiler Performance Trials - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250922272861\/en\/2585586\/22\/provia-availability-for-2026-season.jpg","datePublished":"2025-09-22T11:04:04+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250922272861\/en\/2585586\/22\/provia-availability-for-2026-season.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250922272861\/en\/2585586\/22\/provia-availability-for-2026-season.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/confluence-genetics-partners-with-ag-partners-cooperative-to-increase-commercial-acres-of-provia-soybeans-following-successful-broiler-performance-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Confluence Genetics Partners With Ag Partners Cooperative to Increase Commercial Acres of ProVIA\u2122 Soybeans Following Successful Broiler Performance Trials"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61900","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61900"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61900\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61900"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61900"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61900"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}